|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 9/00 | |
| C07J 41/00 | |||
| A61K 31/575 | |||
| A61P 1/00 | |||
| A61P 1/16 | |||
| C07J 71/00 | |||
| C07J 31/00 |
| (11) | Number of the document | 3360882 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18163623.4 |
| Date of filing the European patent application | 2014-05-14 | |
| (97) | Date of publication of the European application | 2018-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361823169 P | 2013-05-14 | US |
| (72) |
PELLICCIARI, Roberto, IT
|
| (73) |
Intercept Pharmaceuticals, Inc.,
10 Hudson Yards, 37th Floor, New York, NY 10001,
US
|
| (54) | 11-HYDROXYL-6-SUBSTITUTED-DERIVATIVES OF BILE ACIDS AND AMINO ACID CONJUGATES THEREOF AS FARNESOID X RECEPTOR MODULATORS |
| 11-HYDROXYL-6-SUBSTITUTED-DERIVATIVES OF BILE ACIDS AND AMINO ACID CONJUGATES THEREOF AS FARNESOID X RECEPTOR MODULATORS |